Instructions: Use the pencil icon in the top right to edit the form below. ↗️ Remember to push PUBLISH when you are done to save your work.
Statin Initiation Goals:
Received Prescription - ASCVD (Cohort): goal of 20 of those who come in for a f/u visit
Received Prescription - LDL ≥190 mg/DL (Cohort): goal of 25 of those who come in for a f/u visit
Received Prescription - Diabetes and LDL 70-189 mg/DL (Cohort): goal of 50 of those who come in for a f/u visit
Important Health Center Context Fill out this section during your planning process | |
---|---|
Internal Characteristics | |
What are the characteristics of your health center? (rural/urban; other demographic variables, use of expanded care team, culture)? |
|
What are the infrastructure characteristics of your health center (use of expanded care team, culture)? |
|
How do interventions and/or workflows need to be adapted to ensure health equity? |
|
How complex are the patient interventions to implement (e.g., perceived difficulty of implementation, reflected by duration, scope, radicalness, disruptiveness, and number of steps required)? |
|
What are key characteristics of the participating setting(s)? |
|
External Characteristics | |
What external or environmental supports or threats are there? |
|
Plan | Actual |
Describe Intervention Chosen intervention: Provider Professional Development Plan for intervention:
| Chosen Intervention: Provider Professional Development
|
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned: 100% of PCPs will receive education on cholesterol guidelines & strategies to overcome patient hesitancy | Reach of implementers/providers? Actual: #of PCPs? |
Reach of patients: 50% of patients at high risk for a cardiovascular event will receive education using a validated clinical reference tool. | Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working?
| Were you able to accurately measure how your intervention was working?
|
What outcomes do you expect?
| What outcomes have you seen?
|
How will you ensure your intervention will be effective for your target population?
| Did your intervention reach the target population?
|
What unintended consequences or outcomes might there be? | What unintended outcomes did you experience?
|
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? Dr. Stevenson Chery (CMO); Yes |
How will you know if clinicians/care teams/sites used the intervention? | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? | How will you spread your intervention and lessons learned? Awarding sites for all other CQ measures to encourage understanding of measures and drive performance. |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
Intervention #2 Plan | Intervention #2 Actual |
Describe Intervention Chosen intervention: PCN Previsit Planning Plan for intervention:
| Chosen Intervention: PCN Previsit Planning Date when implemented: Updates: |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers?
| Reach of implementers/providers? Actual: 3 PCNs |
Reach of patients?
| Reach of patients? Actual: reports are in Epic, can run them 3/8 and populate then |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working?
| Were you able to accurately measure how your intervention was working? |
What outcomes do you expect? Increase in Statin Rx & cholesterol screening measures | What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population? Cohort f/u and rx performance increase | Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. PCNs (n=3, across 4 sites) | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention? restructured daily huddle - reporting on patients coming in - challenge is that the patient must be on schedule on the prior day, QI nurse is put in PHN role 1 day/week and looking at patient screenings and care gaps, including statin therapy | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? using Epic huddle form with addition of statin therapy piece (handwrite on huddle form), can look at paper form to see if they are followed or not - scanned into folder and can go back and check statin piece | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: reports are ran monthly to see changes | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
Version | Date | Comment |
---|---|---|
Current Version (v. 17) | Apr 10, 2024 20:24 | Antoinette Anwar |
v. 25 | May 06, 2024 14:04 | Antoinette Anwar |
v. 24 | Apr 23, 2024 17:56 | Chris Espersen |
v. 23 | Apr 23, 2024 14:24 | Antoinette Anwar |
v. 22 | Apr 18, 2024 14:37 | Antoinette Anwar |
v. 21 | Apr 17, 2024 15:42 | Antoinette Anwar |
v. 20 | Apr 10, 2024 20:45 | Antoinette Anwar |
v. 19 | Apr 10, 2024 20:36 | Antoinette Anwar |
v. 18 | Apr 10, 2024 20:28 | Antoinette Anwar |
v. 17 | Apr 10, 2024 20:24 | Antoinette Anwar |
v. 16 | Apr 09, 2024 13:11 | Antoinette Anwar |
v. 15 | Feb 27, 2024 18:39 | Chris Espersen |
v. 14 | Feb 08, 2024 16:39 | Antoinette Anwar |
v. 13 | Feb 08, 2024 16:09 | Antoinette Anwar |
v. 12 | Jan 26, 2024 14:25 | PAAnderson (Unlicensed) |
v. 11 | Jan 24, 2024 14:38 | PAAnderson (Unlicensed) |
v. 10 | Jan 05, 2024 18:37 | Lauren Becker |
v. 9 | Dec 28, 2023 14:43 | PAAnderson (Unlicensed) |
v. 8 | Dec 28, 2023 13:22 |
PAAnderson (Unlicensed) Reverted from v. 6 |
v. 7 | Dec 27, 2023 17:55 | PAAnderson (Unlicensed) |
v. 6 | Dec 06, 2023 18:28 | Chris Espersen |
v. 5 | Dec 06, 2023 14:30 | Antoinette Anwar |
v. 4 | Nov 02, 2023 18:14 | Antoinette Anwar |
v. 3 | Nov 02, 2023 17:39 | Antoinette Anwar |
v. 2 | Oct 13, 2023 18:39 | Lauren Becker |
v. 1 | Sept 18, 2023 20:30 | Lauren Becker |
Add Comment